BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 786650)

  • 1. Tumour-associated antibodies against renal cell carcinomas detected by immunofluorescence.
    Ackermann R
    Eur Urol; 1975; 1(3):154-6. PubMed ID: 786650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract.
    Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
    N Engl J Med; 1974 Sep; 291(13):637-41. PubMed ID: 4859212
    [No Abstract]   [Full Text] [Related]  

  • 4. Production and characterization of xenogeneic antisera to a human renal cell carcinoma-associated antigen.
    Ghose T; Belitsky P; Tai J; Janigan DT
    J Natl Cancer Inst; 1979 Aug; 63(2):301-8. PubMed ID: 88535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral cytotoxicity in human renal cell carcinoma.
    Hakala TR; Castro AE; Elliott AY; Fraley EE
    Invest Urol; 1974 Mar; 11(5):405-10. PubMed ID: 4592928
    [No Abstract]   [Full Text] [Related]  

  • 6. The capillary tube leucocyte migration technique (LMT) as a method for detection of serum inhibiting activity of tumour-directed, cellular hypersensitivity in patients with renal carcinomas.
    Kjoer M
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Apr; 82(2):294-6. PubMed ID: 4528017
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical significance of antibodies to ovarian antigens; association with cancer of the genito-urinary tract.
    Forbes AP; Lake JR; Bloch KJ
    Clin Exp Immunol; 1976 Mar; 23(3):436-43. PubMed ID: 780012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transitional cell and renal carcinoma: cell-mediated immunity as determined by the lymphocyte titration technique.
    Hakala TR
    Natl Cancer Inst Monogr; 1978 Dec; (49):151-2. PubMed ID: 571043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of monoclonal antibodies using spleen cells from nude mice bearing human tumors.
    Al Saati T; Blancher A; Calvas P; Neulat-Duga I; Delsol G
    Ann Pathol; 1987; 7(1):1-8. PubMed ID: 3040026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins.
    Holthöfer H; Miettinen A; Paasivuo R; Lehto VP; Linder E; Alfthan O; Virtanen I
    Lab Invest; 1983 Sep; 49(3):317-26. PubMed ID: 6193332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating cytotoxic anti-RCC antibody responses in renal cell carcinoma patients.
    Ishibashi M; Matsuda M; Osafune M; Nakano E; Fujioka H; Takaha M; Sonoda T; Kotake T; Watanabe S
    Hinyokika Kiyo; 1983 Feb; 29(2):121-9. PubMed ID: 6677115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunobiology of genitourinary tumors.
    Lange PH; Hakala TR; Fraley EE
    Urology; 1973 Nov; 2(5):485-92. PubMed ID: 4358375
    [No Abstract]   [Full Text] [Related]  

  • 13. [Autoimmunity in patients with bronchogenic carcinomas: occurrence of antibodies against nuclear antigens, chromosomes and ds-deoxyribonucleic acid].
    Dellen H; Seemayer NH
    Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Sep; 177(6):451-68. PubMed ID: 6322478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies to human renal cell carcinoma: recognition of shared and restricted tissue antigens.
    Vessella RL; Moon TD; Chiou RK; Nowak JA; Arfman EW; Palme DF; Peterson GA; Lange PH
    Cancer Res; 1985 Dec; 45(12 Pt 1):6131-9. PubMed ID: 3904980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous antibodies eluted from membrane fragments in human ovarian epithelial neoplastic effusions. II. Tissue specificity and reactivity.
    Kutteh WH; Doellgast GJ
    J Natl Cancer Inst; 1986 May; 76(5):797-804. PubMed ID: 3517453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
    Stiller-Winkler R; Stark M; Idel H
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of lung carcinoma-associated antibodies from immune complexes and production of heterologous antisera.
    Cronin WJ; Dorsett BH; Ioachim HL
    Cancer Res; 1982 Jan; 42(1):292-300. PubMed ID: 7032694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating antibody to renal collecting ducts in patients with hepatoma or renal-cell carcinoma.
    Forbes AP; Lake JR; Bloch KJ
    Clin Exp Immunol; 1975 Dec; 22(3):426-30. PubMed ID: 178472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma.
    Ait-Tahar K; Liggins AP; Collins GP; Campbell A; Barnardo M; Lawrie C; Moir D; Hatton C; Banham AH; Pulford K
    Br J Haematol; 2009 Aug; 146(4):396-407. PubMed ID: 19552722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomas.
    Bander NH; Finstad CL; Cordon-Cardo C; Ramsawak RD; Vaughan ED; Whitmore WF; Oettgen HF; Melamed MR; Old LJ
    Cancer Res; 1989 Dec; 49(23):6774-80. PubMed ID: 2684399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.